Method for treating amyloidosis

Abstract From the Canadian patent

Therapeutic compounds and methods for inhibiting amyloid deposition in a subject, whatever its clinical setting are described. Amyloid deposition is , inhibited by the administration to a subject of an effective amount of a therapeutic compound comprising an anionic group and a carrier molecule or a , pharmaceutically acceptable salt thereof such that an interaction between an , amyloidogenic protein and a basement membrane constituent is inhibited. Preferred anionic groups are sulfonates and sulfates. Preferred carrier molecules include carbohydrates, polymers peptides, peptide derivatives, aliphatic groups alicyclic groups, heterocyclic groups, aromatic groups and combinations …